Adding HIPEC Boosts Survival in Recurrent Ovarian Cancer

(MedPage Today) -- Adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery significantly improved overall survival (OS) in women with platinum-sensitive, recurrent epithelial ovarian carcinoma, a phase III randomized trial...